RxDoctor Payments Data

Mariko Brandon, MD

Psychiatry · Clearwater, FLNPI 1548603673

Payments from drug & device makers

$4,555in general payments, 2019–2025

Across 261 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Neurocrine Biosciences, Inc.$624
  • Otsuka America Pharmaceutical, Inc.$334
  • Vanda Pharmaceuticals Inc.$320
  • Johnson & Johnson$225
  • plus $738 from 9 others

What the payments were for

  • Food & beverage$4,555100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,555 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$10,327
Medicare patients
47
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate26$238,488
IngrezzaValbenazine Tosylate14$117,322
Invega SustennaPaliperidone Palmitate37$102,822
VraylarCariprazine Hcl52$73,947
Risperdal ConstaRisperidone Microspheres52$48,906
Aripiprazole174$37,864
RexultiBrexpiprazole20$30,431
Lurasidone Hcl99$23,085
TrintellixVortioxetine Hydrobromide32$21,165
Paliperidone ErPaliperidone14$10,277
Ziprasidone Hcl49$6,552
ConcertaMethylphenidate Hcl15$6,191
Duloxetine Hcl180$6,087
Trazodone Hcl345$4,668
Buspirone Hcl191$4,327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna, Risperdal Consta, Concerta$225$396,407130 claims
Neurocrine Biosciences, Inc.Ingrezza$624$117,32214 claims
AbbVieVraylar$1,211$73,94752 claims
Otsuka America Pharmaceutical, Inc.Rexulti$334$30,43120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →